| The MYC oncogene cooperates with sterol-regulated element-binding protein to regulate lipogenesis essential for neoplastic growth AM Gouw, K Margulis, NS Liu, SJ Raman, A Mancuso, GG Toal, L Tong, ... Cell metabolism 30 (3), 556-572. e5, 2019 | 145 | 2019 |
| Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma AM Gouw, LS Eberlin, K Margulis, DK Sullivan, GG Toal, L Tong, RN Zare, ... Proceedings of the National Academy of Sciences 114 (17), 4300-4305, 2017 | 128 | 2017 |
| MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint BAH Smith, A Deutzmann, KM Correa, CS Delaveris, R Dhanasekaran, ... Proceedings of the National Academy of Sciences 120 (11), e2215376120, 2023 | 18 | 2023 |
| Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells R Du, DK Sullivan, NG Azizian, Y Liu, Y Li BMC cancer 21, 1-13, 2021 | 16 | 2021 |
| mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters Y Liu, NG Azizian, DK Sullivan, Y Li Nature communications 13 (1), 7047, 2022 | 14 | 2022 |
| MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes DK Sullivan, A Deutzmann, J Yarbrough, MS Krishnan, AM Gouw, ... Oncogene 41 (45), 4960-4970, 2022 | 13 | 2022 |
| Accurate quantification of single-cell and single-nucleus RNA-seq transcripts using distinguishing flanking k-mers K Eldjárn Hjörleifsson, DK Sullivan, NP Swarna, G Holley, P Melsted, ... bioRxiv, 2022.12. 02.518832, 2022 | 10 | 2022 |
| Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo NG Azizian, DK Sullivan, L Nie, S Pardo, D Molleur, J Chen, ST Weintraub, ... Journal of proteome research 20 (1), 858-866, 2020 | 10 | 2020 |
| Neural networks for clinical order decision support JX Wang, DK Sullivan, AJ Wells, AC Wells, JH Chen AMIA Summits on Translational Science Proceedings 2019, 315, 2019 | 10 | 2019 |
| kallisto, bustools, and kb-python for quantifying bulk, single-cell, and single-nucleus RNA-seq DK Sullivan, KHJ Min, KE Hjörleifsson, L Luebbert, G Holley, L Moses, ... bioRxiv, 2023 | 6 | 2023 |
| ClinicNet: machine learning for personalized clinical order set recommendations JX Wang, DK Sullivan, AC Wells, JH Chen JAMIA open 3 (2), 216-224, 2020 | 6 | 2020 |
| Flexible parsing, interpretation, and editing of technical sequences with splitcode DK Sullivan, L Pachter bioRxiv, 2023 | 3* | 2023 |
| Efficient and accurate detection of viral sequences at single-cell resolution reveals novel viruses perturbing host gene expression L Luebbert, DK Sullivan, M Carilli, KE Hjörleifsson, AV Winnett, T Chari, ... bioRxiv, 2023 | 2 | 2023 |
| Universal preprocessing of single-cell genomics data AS Booeshaghi, DK Sullivan, L Pachter bioRxiv, 2023 | 1 | 2023 |
| The impact of package selection and versioning on single-cell RNA-seq analysis JM Rich, L Moses, PH Einarsson, K Jackson, L Luebbert, AS Booeshaghi, ... bioRxiv, 2024.04. 04.588111, 2024 | | 2024 |
| De novo mutation discovery in a mouse model and a human patient sample of non-Hodgkin's lymphoma DK Sullivan, E Albinali, M Boffelli, L Pachter Cancer Research 84 (6_Supplement), 6246-6246, 2024 | | 2024 |
| Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma A Deutzmann, DK Sullivan, R Dhanasekaran, W Li, X Chen, L Tong, ... Nature Communications 15 (1), 963, 2024 | | 2024 |
| mTOR inhibition attenuates chemosensitivity through induction of a persister state Y Liu, N Azizian, D Sullivan, Y Li Cancer Research 83 (7_Supplement), 1692-1692, 2023 | | 2023 |
| Leveraging Video Game Playing to Improve Computational Biology Research D Sullivan Intersect: The Stanford Journal of Science, Technology, and Society 10 (2), 2017 | | 2017 |
| Abstract A48: Gene expression signatures associated with MYC oncogene addiction in lymphoma D Koch, S Adams, A Gentles, B Anchang, D Sullivan, S Plevritis, ... Molecular Cancer Therapeutics 13 (10_Supplement), A48-A48, 2015 | | 2015 |
Dean FelsherProfessor of Medicine-Oncology, Pathology, Stanford UniversityVerified email at stanford.edu
